Tag: Diovan
AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
FDA: Risk From Tainted Blood Pressure Drugs Very Low
Officials say actual risk to patients from tainted medications is likely lower than originally stated
FDA Approves New Generic Valsartan to Ease Shortage
Certain lots of valsartan recalled due to contamination with trace amounts of nitrosamine
Teva Recalls Two Blood Pressure Medications
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
FDA Finds Another Carcinogen in Certain Valsartan Heart Meds
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
No Apparent Short-Term Cancer Risk From Recalled Valsartan
For single cancer outcomes, risk for colorectal, uterine cancer increased, but not significantly so
FDA Recalls Drugs Containing Active Ingredient Valsartan
All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled
